Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Distribution and excretion of four tetracycline analogues in normal young men.

Literature DB >> 14412746

Distribution and excretion of four tetracycline analogues in normal young men.

Abstract

Entities: Chemical Species

Keywords: CHLORTETRACYCLINE/metabolism; CHLORTETRACYCLINE/related compounds; OXYTETRACYCLINE/metabolism; TETRACYCLINE/metabolism

Mesh：

Substances：

Year: 1959 PMID： 14412746 PMCID： PMC441783 DOI： 10.1172/JCI103974

Source DB: PubMed Journal: J Clin Invest ISSN： 0021-9738 Impact factor: 14.808

× No keyword cloud information.

19 in total

1. Demethylchlortetracycline; a new tetracycline antibiotic that yields greater and more sustained antibacterial activity.

Authors: C M KUNIN; M FINLAND
Journal: N Engl J Med Date: 1958-11-20 Impact factor: 91.245

2. Antibacterial activity of serum of normal subjects after oral doses of demethylchlortetracycline, chlortetracycline and oxytetracycline.

Authors: H A HIRSCH; M FINLAND
Journal: N Engl J Med Date: 1959-05-28 Impact factor: 91.245

3. Antibacterial activity of serum of normal men after oral doses of erythromycin propionate and triacetyloleandomycin.

Authors: H A HIRSCH; C M KUNIN; M FINLAND
Journal: N Engl J Med Date: 1959-02-26 Impact factor: 91.245

4. The concentration of tetracycline in the serum following parenteral administration.

Authors: B KENT; E M YOW; E TOWNSEND
Journal: J Lab Clin Med Date: 1956-02

5. Tetracycline: clinical and pharmacologic studies.

Authors: W S WADDINGTON; G G BERGY; R L NIELSEN; W M KIRBY
Journal: Am J Med Sci Date: 1954-08 Impact factor: 2.378

6. On the distribution of terramycin in different tissues.

Authors: S HELANDER; L E BOTTIGER
Journal: Acta Med Scand Date: 1953

7. The renal clearance and plasma protein binding of aureomycin in man.

Authors: J H SIROTA; A SALTZMAN; H WARMBRAND
Journal: J Pharmacol Exp Ther Date: 1950-10 Impact factor: 4.030

26 in total

1. Modification of the pharmacokinetics and dosage of cefuroxime by endotoxin-induced fever in buffalo calves.

Authors: R K Chaudhary; A K Srivastava; S Rampal
Journal: Vet Res Commun Date: 1999-10 Impact factor: 2.459

Review 2. Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.

Authors: L A Pagliaro; L Z Benet
Journal: J Pharmacokinet Biopharm Date: 1975-10

10. Relation between lipophilicity and pharmacological behavior of minocycline, doxycycline, tetracycline, and oxytetracycline in dogs.

Authors: M Barza; R B Brown; C Shanks; C Gamble; L Weinstein
Journal: Antimicrob Agents Chemother Date: 1975-12 Impact factor: 5.191

Distribution and excretion of four tetracycline analogues in normal young men.

1. Demethylchlortetracycline; a new tetracycline antibiotic that yields greater and more sustained antibacterial activity.

2. Antibacterial activity of serum of normal subjects after oral doses of demethylchlortetracycline, chlortetracycline and oxytetracycline.

3. Antibacterial activity of serum of normal men after oral doses of erythromycin propionate and triacetyloleandomycin.

4. The concentration of tetracycline in the serum following parenteral administration.

5. Tetracycline: clinical and pharmacologic studies.

6. On the distribution of terramycin in different tissues.

7. The renal clearance and plasma protein binding of aureomycin in man.

1. Modification of the pharmacokinetics and dosage of cefuroxime by endotoxin-induced fever in buffalo calves.

Review 2. Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.

3. EVALUATION OF PHENOXYPENICILLINS.

4. A COMPARISON OF FOUR PHENOXYPENICILLINS.

5. CHLORTETRACYCLINE AND OXYTETRACYCLINE IN EXPERIMENTAL E. COLI PYELONEPHRITIS.

6. Comparative in vivo experiments on the tetracycline analogues.

7. Demethylchlortetracycline.

8. Bioavailability of commercial tetracycline products.

9. ANNOTATIONS.

10. Relation between lipophilicity and pharmacological behavior of minocycline, doxycycline, tetracycline, and oxytetracycline in dogs.